Human tumor expression of CD47 has been shown to correlate with the expression of various co-inhibitory markers, such as program cell death protein 1 (PD-1) and cytotoxic T-lymphocyte associated protein 4 (CTLA-4), on tumor-infiltrating CD4+ and CD8+ T cells (72, 73). Here, CTLA4 is linked to neoplasm.